insights_auto
Why is INO down 10,49%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,45 $
arrow_downward
-10,49%(-0,17) 1D
1,14 $
arrow_downward
-21,37% (-0,31)todayPre-market
Closed: 5 қар., 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,57 $
High
1,59 $
Low
1,40 $
Mkt. cap
149,93 млн
Avg. vol.
15,72 млн
Volume
0,00
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,57 $
High
1,59 $
Low
1,40 $
Mkt. cap
149,93 млн
Avg. vol.
15,72 млн
Volume
0,00
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
GuruFocus
·
1 сағат бұрын
INOVIO Pharmaceuticals (INO) Announces $75M Public Offering, Sha
Investing.com
·
4 сағат бұрын
Inovio prices $75 million public offering at $1.05 per share
TradingView
·
5 сағат бұрын
Inovio Announces Pricing Of Approximately $75 Million Public Offering At $1.05 Per Share
Quantisnow
·
5 сағат бұрын
INOVIO Announces Pricing of Approximately $75 Million Public Offering
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc